Broken Moats on X
$CHRW shareholders not buying. Incredible amount of uncertainty in brokerage and how that will look in a few years from litigation impacts on costs (insurance and liability) and AI on margins/take rates. It is a phenomenal deal for $QXO shareholders as they get to exit at cyclical high pricing into incredible uncertainty. (why CHRW down) Also in your multiple assessment above, you need to consider a whole bunch more factors than putting a multiple on a several year out synergy target number (1 chew trading under 20x forward 27' numbers), Ch share count will increase 16%+ (for accretion/dilution scenerios), debt costs will significantly increase (that is stripped out of there) as well as all the severance and integration costs they will incur in the next few years. This deal is quite risky in my opinion. I Also as someone in your shoes knows covering the industry for years, the history of Brokerage acquisitions paying off is quite poor (just see QXO's Coyote acquisition a few years ago)
